Applied Dna Sciences Inc (NASDAQ:BNBX – Get Free Report) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 173,283 shares, an increase of 213.0% from the June 15th total of 55,360 shares. Currently, 2.6% of the company’s stock are short sold. Based on an average daily volume of 271,228 shares, the days-to-cover ratio is presently 0.6 days.
Applied Dna Sciences Trading Down 56.2%
NASDAQ:BNBX traded down $0.21 on Monday, hitting $0.17. The stock had a trading volume of 3,021,774 shares, compared to its average volume of 537,925. The firm has a market cap of $1.19 million, a PE ratio of -0.00 and a beta of 0.52. Applied Dna Sciences has a 1 year low of $0.15 and a 1 year high of $7.15. The firm’s fifty day simple moving average is $0.44.
Applied Dna Sciences (NASDAQ:BNBX – Get Free Report) last posted its earnings results on Friday, May 15th. The company reported ($0.68) EPS for the quarter. The firm had revenue of $1.02 million for the quarter. Applied Dna Sciences had a negative return on equity of 349.95% and a negative net margin of 1,647.25%.
Analysts Set New Price Targets
View Our Latest Report on Applied Dna Sciences
Applied Dna Sciences Company Profile
Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.
Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.
Further Reading
- Five stocks we like better than Applied Dna Sciences
- China’s Helium Ban Could Reshape the AI Supply Chain
- Analysts See Major Upside for These 5 Stocks
- AMD’s 5C Deal Positions It as a Direct NVIDIA Rival
- AST SpaceMobile’s Next Launches Could Decide Whether Its Rally Regains Orbit
Receive News & Ratings for Applied Dna Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Dna Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
